Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,458 | -30,352 | -19,038 | -5,163 | -21,654 |
| Depreciation Amortization | 62 | 47 | 32 | 16 | 70 |
| Accounts payable and accrued liabilities | 5,581 | 1,064 | 2,040 | 170 | N/A |
| Other Working Capital | 6,851 | 2,357 | 1,040 | 107 | 135 |
| Other Operating Activity | 17,192 | 6,548 | 4,661 | -145 | 552 |
| Operating Cash Flow | $-29,772 | $-20,336 | $-11,265 | $-5,015 | $-20,897 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -11 | -7 | -3 | -20 |
| Net Acquisitions | 1,450 | 1,450 | 1,450 | N/A | 0 |
| Purchase Of Investment | -69,763 | -48,264 | -32,087 | -31,087 | N/A |
| Sale Of Investment | 62,903 | 29,965 | 15,725 | 4,200 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -35,380 |
| Investing Cash Flow | $-5,420 | $-16,860 | $-14,919 | $-26,890 | $-35,400 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 145,506 | 14,250 | 14,250 | 14,250 | N/A |
| Other Financing Activity | -5,366 | 993 | -213 | -213 | 85,715 |
| Financing Cash Flow | $140,140 | $15,243 | $14,037 | $14,037 | $85,715 |
| Beginning Cash Position | 63,250 | 63,250 | 63,250 | 63,250 | 33,832 |
| End Cash Position | 168,198 | 41,297 | 51,103 | 45,382 | 63,250 |
| Net Cash Flow | $104,948 | $-21,953 | $-12,147 | $-17,868 | $29,418 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,772 | -20,336 | -11,265 | -5,015 | -20,897 |
| Capital Expenditure | -10 | -11 | -7 | -3 | N/A |
| Free Cash Flow | -29,782 | -20,347 | -11,272 | -5,018 | -20,897 |